Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate.

Scott AE, Ngugi SA, Laws TR, Corser D, Lonsdale CL, D'Elia RV, Titball RW, Williamson ED, Atkins TP, Prior JL.

J Immunol Res. 2014;2014:392170. doi: 10.1155/2014/392170. Epub 2014 May 7.

2.

Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.

Silva EB, Goodyear A, Sutherland MD, Podnecky NL, Gonzalez-Juarrero M, Schweizer HP, Dow SW.

Infect Immun. 2013 Dec;81(12):4626-34. doi: 10.1128/IAI.00915-13. Epub 2013 Oct 7.

3.

A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.

Nieves W, Petersen H, Judy BM, Blumentritt CA, Russell-Lodrigue K, Roy CJ, Torres AG, Morici LA.

Clin Vaccine Immunol. 2014 May;21(5):747-54. doi: 10.1128/CVI.00119-14. Epub 2014 Mar 26.

4.

Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.

Scott AE, Burtnick MN, Stokes MG, Whelan AO, Williamson ED, Atkins TP, Prior JL, Brett PJ.

Infect Immun. 2014 Aug;82(8):3206-13. doi: 10.1128/IAI.01847-14. Epub 2014 May 27.

5.

Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis.

Ngugi SA, Ventura VV, Qazi O, Harding SV, Kitto GB, Estes DM, Dell A, Titball RW, Atkins TP, Brown KA, Hitchen PG, Prior JL.

Vaccine. 2010 Nov 3;28(47):7551-5. doi: 10.1016/j.vaccine.2010.08.058. Epub 2010 Sep 15.

PMID:
20837078
6.

Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis.

Nelson M, Prior JL, Lever MS, Jones HE, Atkins TP, Titball RW.

J Med Microbiol. 2004 Dec;53(Pt 12):1177-82.

PMID:
15585494
7.

Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.

Su YC, Wan KL, Mohamed R, Nathan S.

Vaccine. 2010 Jul 12;28(31):5005-11. doi: 10.1016/j.vaccine.2010.05.022. Epub 2010 May 21.

PMID:
20546831
8.

A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.

Nieves W, Asakrah S, Qazi O, Brown KA, Kurtz J, Aucoin DP, McLachlan JB, Roy CJ, Morici LA.

Vaccine. 2011 Oct 26;29(46):8381-9. doi: 10.1016/j.vaccine.2011.08.058. Epub 2011 Aug 24.

9.

Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.

Sarkar-Tyson M, Smither SJ, Harding SV, Atkins TP, Titball RW.

Vaccine. 2009 Jul 16;27(33):4447-51. doi: 10.1016/j.vaccine.2009.05.040. Epub 2009 May 31.

PMID:
19490962
10.

Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice.

Sangdee K, Waropastrakul S, Wongratanachewin S, Homchampa P.

Southeast Asian J Trop Med Public Health. 2011 Sep;42(5):1190-6.

PMID:
22299445
11.

Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.

Harland DN, Chu K, Haque A, Nelson M, Walker NJ, Sarkar-Tyson M, Atkins TP, Moore B, Brown KA, Bancroft G, Titball RW, Atkins HS.

Infect Immun. 2007 Aug;75(8):4173-80. Epub 2007 May 21.

12.

Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice.

Chin CY, Tan SC, Nathan S.

Front Cell Infect Microbiol. 2012 Jun 15;2:85. doi: 10.3389/fcimb.2012.00085. eCollection 2012.

13.

Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.

Burtnick MN, Heiss C, Roberts RA, Schweizer HP, Azadi P, Brett PJ.

Front Cell Infect Microbiol. 2012 Aug 15;2:108. doi: 10.3389/fcimb.2012.00108. eCollection 2012.

15.

Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.

Scott AE, Laws TR, D'Elia RV, Stokes MG, Nandi T, Williamson ED, Tan P, Prior JL, Atkins TP.

Clin Vaccine Immunol. 2013 Jul;20(7):1041-7. doi: 10.1128/CVI.00113-13. Epub 2013 May 15.

16.

Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.

Moustafa DA, Scarff JM, Garcia PP, Cassidy SK, DiGiandomenico A, Waag DM, Inzana TJ, Goldberg JB.

PLoS One. 2015 Jul 6;10(7):e0132032. doi: 10.1371/journal.pone.0132032. eCollection 2015.

17.

Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis.

Casey WT, Spink N, Cia F, Collins C, Romano M, Berisio R, Bancroft GJ, McClean S.

Vaccine. 2016 May 17;34(23):2616-21. doi: 10.1016/j.vaccine.2016.03.088. Epub 2016 Apr 16.

PMID:
27091689
18.

Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.

Medaglini D, Ciabattini A, Spinosa MR, Maggi T, Marcotte H, Oggioni MR, Pozzi G.

Vaccine. 2001 Feb 28;19(15-16):1931-9.

PMID:
11228363
20.

Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis.

Schully KL, Bell MG, Prouty AM, Gallovic MD, Gautam S, Peine KJ, Sharma S, Bachelder EM, Pesce JT, Elberson MA, Ainslie KM, Keane-Myers A.

Int J Pharm. 2015 Nov 30;495(2):849-61. doi: 10.1016/j.ijpharm.2015.09.059. Epub 2015 Sep 28.

PMID:
26428631

Supplemental Content

Support Center